A Phase I Open-Label Dose-Escalation Study of Intravenous BI 2536 Together With Pemetrexed in Previously Treated Patients With Non–Small-Cell Lung Cancer
| Autor: | Ellis, Peter M., Chu, Quincy S., Leighl, Natasha, Laurie, Scott A., Fritsch, Holger, Gaschler-Markefski, Birgit, Gyorffy, Steve, Munzert, Gerd |
|---|---|
| Zdroj: | In Clinical Lung Cancer January 2013 14(1):19-27 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect